Section

Health

Public health, medicine, biotech

PBS NewsHour

Phoenix Fire Department Uses Ice Bags to Combat Heatstroke

The Phoenix Fire Department is utilizing bags of ice as part of a new protocol to combat heatstroke amid extreme temperatures reaching 115 degrees. This method, which allows for rapid cooling of patients, has been shown to be significantly more effective than traditional treatments. With climate change leading to more frequent heatwaves, the initiative aims to reduce heat-related fatalities in the city.

Bias: 4 Sentiment: +0.20
BBC — World

FDA Approves New Treatment for Pancreatic Cancer

The FDA has approved daraxonrasib, a new treatment for pancreatic cancer, which has shown to nearly double patient survival times in clinical trials. The drug targets the mutated KRAS gene, prevalent in many pancreatic tumors, and offers a new option for patients facing this challenging cancer. Common side effects include rash and nausea, with a lower incidence of severe side effects compared to chemotherapy.

Bias: 4 Sentiment: +0.10
NPR — Top Stories

Medicare's $50 obesity drug program sees early adoption

The Bridge program launched on July 1, 2026, enabling certain Medicare beneficiaries to obtain obesity medications for $50 per month. CVS and Walgreens have each reported filling around 100,000 prescriptions since the program's inception.

Bias: 4 Sentiment: +0.10
Ars Technica

Florida Catholic Bishops Reject Attorney General's Call for Vaccine Exemptions

Florida's Catholic bishops have responded to Attorney General James Uthmeier's letter regarding vaccine exemptions, stating that they do not accept religious exemptions for vaccinations. The bishops support vaccination and only allow exemptions for verified medical conditions.

Bias: 4 Sentiment: -0.10
PBS NewsHour

Lindsay Clancy Trial Highlights Issues in Postpartum Mental Health Care

The trial of Lindsay Clancy, accused of killing her children, has highlighted significant issues in postpartum mental health care, including stigma, lack of provider education, and barriers to access. Experts emphasize the need for greater awareness and proactive support for women experiencing postpartum conditions, particularly postpartum psychosis, which affects approximately one in 1,000 women. The case has sparked discussions about the inadequacies of the U.S. healthcare system in addressing maternal mental health needs.

Bias: 14 Sentiment: -0.10
Al Jazeera English

Two Frankfurt Airport Workers Die from Malaria After Mosquito Infection

Two workers at Frankfurt Airport have died from malaria after being infected by a mosquito that likely arrived on a flight. The Robert Koch Institute identified the mosquito as the source and noted that four other infected employees are being treated. Mosquito traps have been deployed at the airport to investigate the origin of the mosquitoes.

Bias: 4 Sentiment: -0.20
TechCrunch

Boston Scientific Reports Cyberattack Causing Global Disruption to Operations

Boston Scientific has reported a cyberattack that is causing significant disruptions to its operations, affecting its IT systems and business applications. The company has not confirmed whether the disruption impacts patients with medical devices. The investigation into the incident is ongoing, and the timeline for restoring operations remains unclear.

Bias: 30 Sentiment: +0.00
New York Post

Lindsay Clancy Trial Concludes with Testimony from Psychiatrist

The trial of Lindsay Clancy concluded with testimony from forensic psychiatrist Dr. Gregory Saathoff, who stated that the prosecution's opening statement minimized Clancy's mental health struggles. Clancy is seeking a not guilty verdict by reason of insanity, claiming severe postpartum psychosis, while the psychiatrist believes she is criminally responsible for her actions. The jury is set to hear closing arguments on Thursday.

Bias: 45 Sentiment: -0.50
The Hill

FDA Approves New Treatment for Advanced Pancreatic Cancer

The FDA has approved daraxonrasib, a new once-daily pill for advanced pancreatic cancer, providing a new treatment option for patients who have not responded to previous therapies. The drug is produced by Revolution Medicines and will be sold under the brand name Rasonque.

Bias: 4 Sentiment: +0.50
Daily Wire

FDA Approves New Treatment for Advanced Pancreatic Cancer

The FDA has approved daraxonrasib, branded as Rasonque, for the treatment of advanced pancreatic cancer. The approval follows a clinical trial showing that the drug nearly doubled median survival rates compared to standard chemotherapy. Experts highlight the significance of this treatment for patients with metastatic pancreatic adenocarcinoma.

Bias: 4 Sentiment: +0.50
NPR — Top Stories

States Implement Strategies to Reduce Hospital Prices

Indiana has introduced new measures to limit hospital charges as part of efforts to control high healthcare costs. This initiative reflects a growing trend among states to address the financial challenges faced by consumers in the healthcare system.

Bias: 4 Sentiment: +0.00
Deutsche Welle

Climate Change Impacts Highlighted Amid Summer Heatwave in Europe and Beyond

The summer of 2026 has seen extreme heat across Europe, resulting in around 14,000 heat-related deaths in Germany and significant economic losses estimated at €180 billion for the EU. Political figures have downplayed the role of climate change, but scientific evidence indicates a strong link between human activities and the current climate crisis, with rising temperatures contributing to severe wildfires and drought conditions affecting agriculture and water supplies.

Bias: 30 Sentiment: -0.50
Daily Mail

Tesco recalls salad products due to potential E. coli contamination

Tesco is recalling its Finest Mozzarella Pearls and Pesto Orzo Salad due to potential contamination with E. coli. The Food Standards Agency has issued a 'do not eat' warning and advised customers to return the product for a full refund. This recall follows a rise in STEC infections in England and is part of ongoing food safety measures.

Bias: 30 Sentiment: -0.10
Al Jazeera English

Flash flood in Nepal results in at least eight fatalities and significant damage

A flash flood in Nepal has killed at least eight people and left 384 tourists missing. The flood caused significant damage to infrastructure in the Rasuwa district, prompting rescue operations and emergency meetings by officials. Climate experts suggest that an avalanche from a glacier may have triggered the flood, highlighting the increasing impact of climate change on extreme weather events in the region.

Bias: 14 Sentiment: -0.50
Deutsche Welle

Flash Floods in Nepal and Tibet Result in Casualties and Missing Persons

A flash flood in Nepal and Tibet has resulted in confirmed deaths and hundreds of missing persons. The floods caused extensive damage to infrastructure and hampered rescue efforts. Both Nepali and Chinese authorities are engaged in rescue operations, with significant numbers of tourists reported missing.

Bias: 4 Sentiment: -1.00
New York Times — US

Parents Weigh Risks of Football Participation for Their Children

A recent study on chronic traumatic encephalopathy (C.T.E.) has prompted parents to reconsider the risks of allowing their children to play football. The study has intensified existing concerns, leaving parents feeling fearful and uncertain about their decisions.

Bias: 4 Sentiment: -0.20
New York Times — US

Hospital Halts Surgeries Following Adverse Reactions in Patients

Ascension Saint Thomas Hospital Midtown in Nashville has suspended all surgeries scheduled for August 14 due to serious adverse reactions experienced by four patients. Further details regarding the patients' conditions have not been provided.

Bias: 4 Sentiment: -1.00
Wired

Study Identifies Genetic Mutation Linked to Drug-Resistant Malaria

A study by Brown University researchers has identified a genetic mutation in malaria parasites that may contribute to drug resistance. The mutation, named PIN, has rapidly spread in Uganda, showing reduced sensitivity to common antimalarial drugs. The findings underscore the need for enhanced surveillance and the development of new treatments.

Bias: 4 Sentiment: +0.00